Table 3.
Glucose metabolism and related parameters of enrolled patients.
| Parameters | Results | |
|---|---|---|
| Mean ± SD | Range | |
| Tg (ng/ml) | 27.2 ± 88.0 | 0.04–500 |
| TgAb (IU/ml) | 143.1 ± 533.3 | 3.91–4,000 |
| TSH (uIU/ml) | 68.0 ± 24.6 | 24.93–150 |
| TG (mmol/L) | 2.2 ± 1.9 | 0.5–21.47 |
| TC (mmol/L) | 5.8 ± 1.4 | 1.16–13.03 |
| LDL-c (mmol/L) | 2.6 ± 1.2 | 0.72–5.86 |
| HDL-c (mmol/L) | 2.1 ± 1.2 | 0.79–6.1 |
| Uric acid (umol/L) | 318.8 ± 95.9 | 4.5–616 |
| HbA1c (%) | 6.0 ± 0.8 | 4.8–11.4 |
| Blood glucose (mmol/L) | ||
| 0 h | 5.1 ± 0.9 | 3.54–9.74 |
| 1 h | 9.9 ± 2.9 | 3.03–21.18 |
| 2 h | 8.7 ± 3.5 | 3.53–24.9 |
| 3 h | 6.2 ± 3.0 | 2.03–22.48 |
| Insulin (uIU/ml) | ||
| 0 h | 11.4 ± 19.6 | 1.95–368.9 |
| 1 h | 94.9 ± 77.0 | 9.33–755.5 |
| 2 h | 102.1 ± 90.1 | 8.46–1,000 |
| 3 h | 48.8 ± 64.3 | 3.41–1,000 |
| C-peptide (ng/ml) | ||
| 0 h | 2.6 ± 1.0 | 0.83–7.46 |
| 1 h | 9.9 ± 3.9 | 1.61–29.75 |
| 2 h | 11.7 ± 4.6 | 2.49–30.29 |
| 3 h | 8.3 ± 3.6 | 2.02–21.52 |
| HOMA-β | 194.6 ± 530.6 | 9.98–7960 |
| HOMA-IR | 2.6 ± 4.2 | 0.39–76.57 |
| ISI | 77.2 ± 28.8 | 15.59–195.93 |
| CSI | 195.5 ± 50.7 | 99.98–359.44 |
| AUC of insulin | 227.0 ± 186.1 | 22.60–2439.95 |
| AUC of C-peptide | 27.1 ± 9.3 | 6.03–60.34 |
SD, standard deviation; Tg, thyroglobulin; Tg-Ab, antithyroglobulin antibody; TSH, thyroid stimulating hormone; TG, triglycerides; TC, total cholesterol; LDL-c, low-density lipoprotein cholesterol; HDL-c, high-density lipoprotein cholesterol; HbA1c, glycosylated hemoglobin; HOMA-β, homeostasis model assessment of β cell; HOMA-IR, homeostasis model assessment of insulin resistance; ISI, insulin sensitivity index; CSI, C-peptide sensitivity index; AUC, area under curve.